These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 6254651)
1. Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines. Findlay DM; Michelangeli VP; Eisman JA; Frampton RJ; Moseley JM; MacIntyre I; Whitehead R; Martin TJ Cancer Res; 1980 Dec; 40(12):4764-7. PubMed ID: 6254651 [TBL] [Abstract][Full Text] [Related]
2. Frequency of 1,25-dihydroxyvitamin D3 receptor in human breast cancer. Eisman JA; Suva LJ; Sher E; Pearce PJ; Funder JW; Martin TJ Cancer Res; 1981 Dec; 41(12 Pt 1):5121-4. PubMed ID: 6272989 [TBL] [Abstract][Full Text] [Related]
3. Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture. Frampton RJ; Suva LJ; Eisman JA; Findlay DM; Moore GE; Moseley JM; Martin TJ Cancer Res; 1982 Mar; 42(3):1116-9. PubMed ID: 6277475 [TBL] [Abstract][Full Text] [Related]
4. 1,25-dihydroxyvitamin D3 receptors in human epithelial cancer cell lines. Colston K; Colston MJ; Fieldsteel AH; Feldman D Cancer Res; 1982 Mar; 42(3):856-9. PubMed ID: 6895862 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites. Frampton RJ; Omond SA; Eisman JA Cancer Res; 1983 Sep; 43(9):4443-7. PubMed ID: 6307514 [TBL] [Abstract][Full Text] [Related]
6. Properties of a calcitonin receptor and adenylate cyclase in BEN cells, a human cancer cell line. Findlay DM; deLuise M; Michelangeli VP; Ellison M; Martin TJ Cancer Res; 1980 Apr; 40(4):1311-7. PubMed ID: 6244091 [TBL] [Abstract][Full Text] [Related]
7. Calcitonin effects on growth and on selective activation of type II isoenzyme of cyclic adenosine 3':5'-monophosphate-dependent protein kinase in T 47D human breast cancer cells. Ng KW; Livesey SA; Larkins RG; Martin TJ Cancer Res; 1983 Feb; 43(2):794-800. PubMed ID: 6184157 [TBL] [Abstract][Full Text] [Related]
8. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. Fitzpatrick SL; LaChance MP; Schultz GS Cancer Res; 1984 Aug; 44(8):3442-7. PubMed ID: 6331647 [TBL] [Abstract][Full Text] [Related]
9. 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Elstner E; Linker-Israeli M; Said J; Umiel T; de Vos S; Shintaku IP; Heber D; Binderup L; Uskokovic M; Koeffler HP Cancer Res; 1995 Jul; 55(13):2822-30. PubMed ID: 7796409 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of calcitonin induction of prolonged activation of adenylate cyclase in human cancer cells. Michelangeli VP; Findlay DM; Moseley JM; Martin TJ J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(2):129-41. PubMed ID: 6315797 [TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Wang Q; Yang W; Uytingco MS; Christakos S; Wieder R Cancer Res; 2000 Apr; 60(7):2040-8. PubMed ID: 10766196 [TBL] [Abstract][Full Text] [Related]
12. Hormone-dependent transformation and nuclear localisation of 1,25-dihydroxyvitamin D3 receptors from human breast cancer cell lines and chick duodenum. Sher E; Martin TJ; Eisman JA Horm Metab Res; 1985 Mar; 17(3):147-51. PubMed ID: 2987093 [TBL] [Abstract][Full Text] [Related]
13. 1,25-dihydroxyvitamin D3 specifically binds to a human breast cancer cell line (T47D) and stimulates growth. Freake HC; Marcocci C; Iwasaki J; MacIntyre I Biochem Biophys Res Commun; 1981 Aug; 101(4):1131-8. PubMed ID: 6272774 [No Abstract] [Full Text] [Related]
14. Characterization of a receptor-like protein for 1,25-dihydroxyvitamin D3 in rat skin. Simpson RU; DeLuca HF Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5822-6. PubMed ID: 6255467 [TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture. Imai Y; Leung CK; Friesen HG; Shiu RP Cancer Res; 1982 Nov; 42(11):4394-8. PubMed ID: 6290036 [TBL] [Abstract][Full Text] [Related]
16. Stimulatory effect of 1,25-dihydroxyvitamin D3 on the glucose-6-phosphate dehydrogenase activity in the MCF-7 human breast cancer cell line. Noun A; Garabedian M; Monet JD Cell Biochem Funct; 1989 Jan; 7(1):1-6. PubMed ID: 2752532 [TBL] [Abstract][Full Text] [Related]
17. Normal and malignant breast tissue is a target organ for 1,25-(0H)2 vitamin D3. Eisman JA; Macintyre I; Martin TJ; Frampton RJ; King RJ Clin Endocrinol (Oxf); 1980 Sep; 13(3):267-72. PubMed ID: 6260398 [TBL] [Abstract][Full Text] [Related]
18. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration. Murphy LJ; Murphy LC; Vrhovsek E; Sutherland RL; Lazarus L Cancer Res; 1984 May; 44(5):1963-8. PubMed ID: 6324992 [TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of human breast cancer cells by 1,25-dihydroxyvitamin D3 is accompanied by induction of apolipoprotein D expression. López-Boado YS; Puente XS; Alvarez S; Tolivia J; Binderup L; López-Otín C Cancer Res; 1997 Sep; 57(18):4091-7. PubMed ID: 9307298 [TBL] [Abstract][Full Text] [Related]
20. Measurement of 1,25-dihydroxyvitamin D3 receptors in breast cancer and their relationship to biochemical and clinical indices. Freake HC; Abeyasekera G; Iwasaki J; Marcocci C; MacIntyre I; McClelland RA; Skilton RA; Easton DF; Coombes RC Cancer Res; 1984 Apr; 44(4):1677-81. PubMed ID: 6322984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]